Tuesday 24 May
Changing face of atherosclerosis
Filippo Crea, Rome, Italy
Filippo Crea is Professor of Cardiology, Director of the Department of Cardiovascular Sciences, Director of the Postgraduate School in Cardiology and Coordinator of the PhD program in Cellular and Molecular Cardiology at the Catholic University in Rome, Italy.
His research activity has primarily focused on studying the multiple mechanisms of myocardial ischaemia in chronic and acute coronary syndromes (ACS). Professor Crea has received numerous research awards including the Arrigo Recordati International Prize for the “Lifetime achievement in researching the pivotal role of microcirculation in systemic and organ diseases”.
He has given prestigious lectureship worldwide including the 7th annual Robert L. Krakoff International Lecture in Cardiovascular Medicine at the Brigham and Women’s Hospital, Harvard University Medical School. He is Editor-in-Chief of the European Heart Journal since September 2020.
Peter Libby, Boston, USA
Julie Redfern, Westmead, Australia
Julie Redfern is a Professor of Public Health and the Research Academic Director (Researcher Development Output and Impact) in the Faculty of Medicine and Health, University of Sydney; a practicing Physiotherapist; and Professorial Fellow at The George Institute for Global Health. She has been a Chief Investigator on research grants totalling $25M in the past 5 years and has published over 190 manuscripts and 4 book chapters. Professor Redfern has held continuous research fellowships from the National Health and Medical Research Council (Australia) and the National Heart Foundation of Australia. She has over15 years of experience developing, testing and implementing scalable strategies to close evidence-practice gaps and improve health outcomes for people with chronic disease. Professor Redfern also has expertise in multidisciplinary and translational research and is an advocate for effective secondary prevention of cardiovascular disease. Professor Redfern currently holds a NHMRC Career Development Fellowship (Investigator Grant Leadership Level 2 commencing in 2022, $AU2.9M) and is CIA on a NHMRC Synergy Grant (SOLVE-CHD, $AU5M). She is Co-Chair of the Clinical and Preventative Cardiology Council of the Cardiac Society of Australia and New Zealand.
Brian Ference, Cambridge, United Kingdom